Home

CytomX Therapeutics, Inc. - Common Stock (CTMX)

0.4571
+0.0015 (0.33%)
NASDAQ · Last Trade: Apr 7th, 3:09 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
Investors are eyeing numerous companies lately, and here's an insight into five of them.
Via AB Newswire · May 3, 2024
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in nature and giving hope to families dealing with a fateful diagnosis. According to the American Cancer […]
Via FinancialNewsMedia · March 24, 2023
CytomX Therapeutics (NASDAQ: CTMX) and Regeneron (NASDAQ: REGN) Enter into Strategic Collaboration to Develop Bispecific Therapies to Treat Cancer
CytomX Therapeutics, Inc. (NASDAQ: CTMX) is a clinical-stage biopharmaceutical company, which is focused on developing innovative treatments for a wide-range
Via Spotlight Growth · November 17, 2022